spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Clinigen expands US site capacity in response to growing demand for Clinical Supplies Management services

Clinigen CTS



In the last 24 months, Clinigen has seen a large increase in demand from pharmaceutical and biotech companies for its tailored Clinical Supplies Management services including packaging and labelling, comparator drug sourcing, global storage and distribution, and biological sample management. As a result, to ensure the continued delivery of industry-leading services to clients, Clinigen is opening new satellite facilities in Fargo, North Dakota and Malvern, Pennsylvania.

Located near the Company’s existing locations, the two new satellite facilities will allow Clinigen to support the continued growth of its GMP storage and distribution and cold-chain management services, with new walk-in refrigerators and freezers, for 2-8°C, - 20°C, as well as -80°C storage.

Shaun Chilton, Chief Executive Officer, Clinigen, said: “Throughout the pandemic, we have seen a continued increase in the demand for our clinical services. With many halted trials starting up again and our pipeline continuing to grow, we are as focused as ever on meeting the needs of our clients and providing the high service levels that are at the heart of why clients choose to work with Clinigen. This investment demonstrates our continued commitment to our clients and reflects their trust in our tailored clinical services offering.”
phone +44 (0)1283 495 010
email ctsinquiries@clinigengroup.com
web www.clinigengroup.com/clinical-trial-services
email Pitcairn House, Crown Square, First Avenue Burton-on-Trent, Staffordshire, DE14 2WW UK
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Gelomics Partners With Rousselot Biomedical to Create the World’s First, Ready-to-Use 3D Cell Culture Kits Based on X-PURE® GelMA

Irving, United States, 16th November 2022 / Sciad Newswire / Darling Ingredients’ Health Brand, Rousselot, the global leader in collagen-based solutions, and Gelomics, the world-leading provider of fully integrated 3D cell, organoid and tissue culture technologies, have entered into a cobranding partnership. Rousselot Biomedical will supply Gelomics with its X-Pure GelMA (gelatin methacryloyl), a photo cross-linkable extracellular matrix, for use in Gelomics’ LunaGel™ 3D Tissue Culture System.
More info >>


White Papers

Managing GxP Environmental Systems to Ensure Data Integrity

Vaisala Ltd


More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement